Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
2
The Residency Report: When can adalimumab be stopped in JIA-associated uveitis
3
IRIS Registry data mined for understanding of pediatric NK
4
Evaluating Safety and Clinical Confidence between Aflibercept 8 mg and 2 mg in Retinal Vascular Diseases
5